Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenda L Swetman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pediatrics|June 26, 2013
Imiquimod, molluscum, and the need for a better “best pharmaceuticals for children” actKenneth A Katz, Glenda L Swetman
The New England Journal of Medicine|January 27, 2012
Sildenafil for severe lymphatic malformationsGlenda L Swetman, David R Berk, Shreyas S Vasanawala, et al.
Journal of the American Academy of Dermatology|March 25, 2014
An open-label study to evaluate sildenafil for the treatment of lymphatic malformationsChristina Danial, Andrea L Tichy, Umar Tariq, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pediatrics|June 26, 2013
Imiquimod, molluscum, and the need for a better “best pharmaceuticals for children” actKenneth A Katz, Glenda L Swetman
The New England Journal of Medicine|January 27, 2012
Sildenafil for severe lymphatic malformationsGlenda L Swetman, David R Berk, Shreyas S Vasanawala, et al.
Journal of the American Academy of Dermatology|March 25, 2014
An open-label study to evaluate sildenafil for the treatment of lymphatic malformationsChristina Danial, Andrea L Tichy, Umar Tariq, et al.
Pageof 1